SEC Form 4 · accession 0001209191-15-075029
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Duncan Higgons
Officer — Chief Operating Officer
Period of report
Oct 7, 2015
Accepted (ET)
Oct 9, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Oct 7, 2015 | G | 70,000 | $0.00 | D | 81,835 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects a gift of shares from the reporting person to charity.